My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2005-136
CBCC
>
Official Documents
>
2000's
>
2005
>
2005-136
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
7/15/2016 12:18:29 PM
Creation date
9/30/2015 8:38:37 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
04/19/2005
Control Number
2005-136
Agenda Item Number
11.I.3
Entity Name
Florida Department of Environmental Protection Agency
Subject
DEP Agreement No. G0143 Grant Awards
Supplemental fields
SmeadsoftID
4876
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
49
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Addendum 2 <br /> Quality Control Requirements for Laboratories Performing Chemical Analysis <br /> In addition to the quality control requirements outlined in Chapter 5 of the NELAC Standards , <br />the <br /> following quality control measures shall be implemented for this Agreement . Note : "Sample" refers to <br /> samples that have been either collected or analyzed under the terms of this Agreement . <br /> 1 . Matrix- Related Quality Control Samples - The GRANTEE shall ensure that samples associated with <br /> this Agreement are used for matrix spikes , and either laboratory duplicates or matrix spike duplicates . <br /> The laboratory shall analyze these samples : <br /> a . The first time samples from a sample collection matrix (see Table FA 1000- 1 ) are submitted to <br /> the laboratory under this Agreement for analysis . The laboratory shall select one or more of the <br /> received samples for use in composition of the matrix spike and duplicates . <br /> b . After the first 20 samples from the sample collection matrix have been analyzed , at least one <br /> matrix spike and either laboratory duplicates or matrix spike duplicates shall be composed using <br /> a sample or samples selected from each additional 20 samples of the sample collection matrix <br /> submitted to the laboratory. <br /> c. The last time samples from the sample collection matrix are received and analyzed . The <br /> laboratory shall select one or more of the received samples for use in composition of the matrix <br /> spike and duplicates . <br /> d . Spike levels must be at the concentrations specified in item 3 below. <br /> e . If the selected sample concentration is expected to be below the Agreement-specified practical <br /> quantitation limit ( PQL) listed in the planning document, then matrix spike duplicates must be <br /> used . <br /> 2 . Per NELAC Chapter 5 requirements , as least one Laboratory Control Sample ( LCS ; also known as <br /> Laboratory Fortified Blank ) shall be prepared , analyzed and evaluated with each batch of 20 samples <br /> or less . <br /> a . The acceptance criteria for the LCS shall be specified in the planning document . <br /> b . If the LCS is unacceptable , the samples associated with the LCS shall be reprocessed with a new <br /> LCS . If the samples cannot be reprocessed , the data must be appropriately qualified . <br /> 3 . For applicable analytes denoted in the planning document, a QC check sample , standard reference <br /> material (SRM ) or other quality control sample , hereinafter identified collectively as quality control <br /> check samples (QCCS ) , shall be processed with each sample preparation batch and analyzed for <br /> evaluation according to the acceptance limits established for the QCCS . <br /> a . Analysis of a QCCS is required for but not limited to the following analyses : <br /> ( i ) Chlorophyll — the assay for the QCCS or its original formulation shall have been determined <br /> by an organization external to the laboratory ; <br /> Biochemical oxygen demand ( BOD ) or carbonaceous BOD (CBOD ) — the method -specified <br /> glucose/glutamic acid check solution shall be used ; and , <br /> ( iii ) Copper in seawater — the QCCS shall be any seawater- matrix SRM assayed by an <br /> organization external to the laboratory . <br /> b . If the QCCS is unacceptable , the samples associated with the QCCS shall be reprocessed with a <br /> new QCCS . If the samples cannot be reprocessed , the data must be appropriately qualified for <br /> all contracted samples in the preparation batch . <br /> 4 . Spiking/Fortification Requirements - All spike fortifications must take place prior to any required <br /> sample preparation steps (e . g . , sample extraction , sample digestion , pH adjustment, etc . ) . The final <br /> concentration of any spike fortification shall be at the applicable level identified below . <br /> a . If any of the samples in the preparation batch are non -detect ( i . e . , below the MDL specified in the <br /> planning document) , the spiking level must not be greater than 2 times the Agreement-specified <br /> PQL . <br /> b . The concentration of a spiked sample cannot exceed 5 times the highest concentration of any <br /> contracted sample in the preparation batch . <br /> 5 . Evaluation of Matrix Spikes - The results of matrix spikes must meet the acceptance criteria specified <br /> by the Agreement and listed in the planning document or the data must be appropriately qualified . <br /> Revised 3/05 <br /> DEP Agreement No . G0143 , Attachment H, Page 8 of 11 <br />
The URL can be used to link to this page
Your browser does not support the video tag.